Eating Behavior Strategies for Childhood Obesity
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different eating behaviors and food access affect childhood obesity. Researchers will examine how controlling or not controlling access to favorite foods influences children's weight and eating habits. Families will participate in two periods: one with limited access to certain foods (Restricted Access Period) and another with free access (Non-Restricted Access Period). Children aged 8-11 who are at risk for obesity or already have obesity and consume certain foods at least twice a week may be suitable for this study. As an unphased study, this trial offers families the chance to contribute to valuable research that could shape future strategies for managing childhood obesity.
Will I have to stop taking my current medications?
If your child is taking medications that affect appetite, such as Ritalin, Adderall, Concerta, Wellbutrin, or Prednisone, they will not be able to participate in the study.
What prior data suggests that these eating behavior strategies are safe for children?
Research shows that time-restricted feeding is generally safe for adults with obesity, with studies finding no major negative effects. Although this trial uses a slightly different method, involving periods when certain foods are restricted, similar approaches are often well-tolerated by children and teenagers.
While this specific trial lacks direct data, related studies in children have examined time-restricted eating and found no major safety issues. Participants in those studies typically experienced safe outcomes, including some weight loss and improvements in health measures like body fat and blood sugar levels.
Overall, related research generally considers the strategies used in this trial safe for children. Careful monitoring during the trial ensures safety and effectiveness.12345Why are researchers excited about this trial?
Researchers are excited about the Eating Behavior Strategies for Childhood Obesity trial because it explores a unique behavioral approach to managing childhood obesity. Unlike traditional treatments such as dietary changes, exercise programs, or medication, this trial focuses on altering food access through periods of restriction and structured intake. This method could offer a more natural and sustainable way to help children develop healthier eating habits by changing their food environment and preferences. By involving parents directly in managing food access, this trial aims to empower families to take proactive steps in addressing obesity, potentially leading to long-lasting behavioral changes.
What evidence suggests that this trial's treatments could be effective for childhood obesity?
Research has shown that time-restricted eating, which involves eating only during certain hours of the day, can aid in weight management. Studies have found that teenagers following this eating pattern lost weight and improved their blood sugar levels. One study reported a noticeable drop in body mass index (BMI) in young people after 12 weeks of intermittent fasting, which is similar to time-restricted eating. However, some research suggests that time-restricted eating might not be more effective for weight loss than eating throughout the day. Its success can depend on personal habits and adherence. In this trial, participants will undergo a Behavioral restriction arm, where their parents will restrict preferred foods for 2 weeks, to evaluate the impact on eating behaviors and weight management.16789
Who Is on the Research Team?
Katherine Balantekin, PhD, RD
Principal Investigator
Clinical Associate Professor
Are You a Good Fit for This Trial?
This trial is for children aged 8-11 who are at risk for obesity or already obese, partly based on their own BMI or their parent's weight. They must enjoy at least half of the study foods and eat them twice a week. Kids with clinical eating disorders, allergies to study foods, not liking most study foods, or taking appetite-affecting meds can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete consent, height/weight/body fat measurements, questionnaires, and tasks including delayed discounting and relative reinforcing value tasks.
Randomized Cross-over Design
Participants undergo two weeks of restricted access and two weeks of non-restricted access, with a one-week washout period in between, including loss of control test meals.
Follow-up
Participants are monitored for changes in zBMI and body fat percentage, with follow-up visits at 6 and 12 months for measurements and tasks.
What Are the Treatments Tested in This Trial?
Interventions
- Non-Restricted Access Period
- Restricted Access Period
Trial Overview
The study examines how lack of control over eating and food restrictions affect kids' risk of becoming obese by monitoring them over a year. It includes periods where access to high-calorie foods is limited and times when it's not to see how this influences eating behavior.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
In the restriction period participants will have their preferred (chosen after doing a preference task, including liking) food and similar alternatives restricted by their parent for 2 weeks. In the structured intake period period, participants and their parents will be given several portions of the preferred food (chosen after doing a preference task, including liking) and will consume it throughout the two-week period.
Find a Clinic Near You
Who Is Running the Clinical Trial?
State University of New York at Buffalo
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Published Research Related to This Trial
Citations
Time-Limited Eating in Pediatric Patients with Obesity
Effects of 8-hour time restricted feeding on body weight and metabolic disease risk factors in obese adults: A pilot study. Nutr Healthy Aging 4 (2018): 345 ...
A time-restricted feeding intervention in children and ...
This study aims to determine both short- and long-term effects of a TRF intervention in children and adolescents with obesity.
Time limited eating in adolescents with obesity (time LEAd)
Time limited eating (TLE) has been shown to be effective for weight loss and improvement of glycemic control in adults with obesity and type 2 diabetes ...
Intermittent fasting as a treatment for obesity in young people
Hegedus et al. reported a significant decrease in body mass index at the 95th percentile at week 12, with a 46% reduction observed in the late ...
Effects of Time-Restricted Eating on Weight Loss and Other ...
Time-restricted eating, in the absence of other interventions, is not more effective in weight loss than eating throughout the day.
Time-restricted eating: Watching the clock to treat obesity
In participants with obesity, time-restricted eating results in 3%–5% weight loss over 2–12 months, versus controls. Reductions in body weight ...
Time limited eating in adolescents with obesity (time LEAd)
Outcomes will include change in total body fat (TBF) percentage measured on DEXA scan, BMI status and fasting blood glucose at 12 weeks compared to baseline.
8.
researchgate.net
researchgate.net/publication/364742358_A_time-restricted_feeding_intervention_in_children_and_adolescents_with_obesity_The_TRansForm_study_protocol(PDF) A time-restricted feeding intervention in children and ...
This study aims to determine both short- and long-term effects of a TRF intervention in children and adolescents with obesity.
Eating Behavior Strategies for Childhood Obesity
Research suggests that time-restricted feeding, where food is consumed within a specific time window, is generally safe for adults with obesity, as no adverse ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.